“…Recently, creation and development of non-natural oligomeric peptide mimics, the so-called peptidomimetics, have become a field of large interest in biomedicine [3]. Examples include peptoids [4], β-peptides [5], γ- and δ-peptides [6], azapeptides [7], α-aminoxy-peptides [8], sugar-based peptides [9], α/β-peptides [10], phenylene ethynylenes [11], and AApeptides [12, 13], to name a few. By introducing unnatural backbones, these oligomers are more stable against proteolysis and are believed to have reduced immunogenicity [14].…”